Vaccines, equity and sovereignty: Science for the world from Colombia.
作者信息
Muñoz-Durango Natalia, Hernández-Ortiz Juan Pablo, Osorio Jorge E
机构信息
Directora de Proyectos Especiales, VaxThera S.A.S., Medellín, Colombia.
Profesor, Universidad de Nacional de Colombia y director, Laboratorio Genómico OneHealth, Universidad Nacional de Colombia, sede Medellín; COO, VaxThera S.A.S., Medellín, Colombia.
出版信息
Biomedica. 2025 May 30;45(2):169-172. doi: 10.7705/biomedica.8030.
Abstract
摘要
相似文献
1
Vaccines, equity and sovereignty: Science for the world from Colombia.
Biomedica. 2025 May 30;45(2):169-172. doi: 10.7705/biomedica.8030.
2
Phenol-free in-house kit for RNA extraction with applicability to SARS-CoV-2 genomic sequencing studies: A contribution to biotechnological sovereignty in Colombia.
J Virol Methods. 2025 May;334:115116. doi: 10.1016/j.jviromet.2025.115116. Epub 2025 Feb 14.
3
Treponema pallidum genetic diversity and its implications for targeted vaccine development: A cross-sectional study of early syphilis cases in Southwestern Colombia.
PLoS One. 2024 Jul 19;19(7):e0307600. doi: 10.1371/journal.pone.0307600. eCollection 2024.
4
IM4Equity: an implementation science meta-framework for community-engaged partnerships to advance health equity.
BMC Health Serv Res. 2025 Mar 26;25(1):437. doi: 10.1186/s12913-025-12537-8.
5
Assessment of venom variation and phylogenetic relationships of Micrurus dumerilii from three different regions of Colombia.
Biochimie. 2025 Aug;235:93-105. doi: 10.1016/j.biochi.2025.06.003. Epub 2025 Jun 9.
6
Chemical Profiles of the Volatilome and Fatty Acids of "Suero Costeño" (Fermented Cream)/Raw Milk from Colombia: Promising Criteria for the Autochthonous-Regional Product Identity Designation.
Molecules. 2025 Jun 9;30(12):2524. doi: 10.3390/molecules30122524.
7
Importance and value of adjuvanted influenza vaccine in the care of older adults from a European perspective - A systematic review of recently published literature on real-world data.
Vaccine. 2022 May 11;40(22):2999-3008. doi: 10.1016/j.vaccine.2022.04.019. Epub 2022 Apr 19.
8
Equity and Inclusion in Assessing Hereditary Cancer Risk: Insights From Excluded Communities, Structured Interviews, and Population Genetics.
Cancer Control. 2025 Jan-Dec;32:10732748251355825. doi: 10.1177/10732748251355825. Epub 2025 Jun 30.
9
Systemic corticosteroids for the treatment of COVID-19: Equity-related analyses and update on evidence.
Cochrane Database Syst Rev. 2022 Nov 17;11(11):CD014963. doi: 10.1002/14651858.CD014963.pub2.
10
A Review of Attacks, Vulnerabilities, and Defenses in Industry 4.0 with New Challenges on Data Sovereignty Ahead.
Sensors (Basel). 2021 Jul 30;21(15):5189. doi: 10.3390/s21155189.
本文引用的文献
1
Contribution of vaccination to improved survival and health: modelling 50 years of the Expanded Programme on Immunization.
Lancet. 2024 May 25;403(10441):2307-2316. doi: 10.1016/S0140-6736(24)00850-X. Epub 2024 May 2.
2
Estimating the global impact of rotavirus vaccines on child mortality.
Int J Infect Dis. 2023 Dec;137:90-97. doi: 10.1016/j.ijid.2023.10.005. Epub 2023 Oct 18.
3
Zika Virus Disease and Pregnancy Outcomes in Colombia.
N Engl J Med. 2020 Aug 6;383(6):537-545. doi: 10.1056/NEJMoa1911023.
4
Forecasting Zika Incidence in the 2016 Latin America Outbreak Combining Traditional Disease Surveillance with Search, Social Media, and News Report Data.
PLoS Negl Trop Dis. 2017 Jan 13;11(1):e0005295. doi: 10.1371/journal.pntd.0005295. eCollection 2017 Jan.
Zotero 插件